Adam Kaplan
Family Medicine · Plano, TXNPI 1245322056
Payments from drug & device makers
Across 646 payments — averaging $1902.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$726K
- Seqirus USA Inc$329K
- GSK$93K
- Hikma Pharmaceuticals USA$59K
- Cue Health Inc.$16K
- Novo Nordisk$2K
- plus $5K from 35 others
What the payments were for
- Food & beverage$5,975100%
- Education$160%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
How this compares
$1,228,825 in reported general payments places this provider in the 95th percentile of 8,760 family medicine providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ultra-Fine Mini Pen NeedlePen Needle, Diabetic | 11 | $584 |
| Atorvastatin Calcium | 13 | $72 |
| Amlodipine Besylate | 11 | $26 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Plano
- Douglas DenhamSan Antonio$68.5M
- Vicki MillerPasadena$58.3M
- Hareshkumar BogharaDesoto$30.3M
- Earl MartinTomball$30.1M
- Lisa HollowayHouston$30.1M
- William SegerFort Worth$27.5M
- Veronica FragosoHouston$24.5M
- Joel SolisMcAllen$21.1M
- George AtieeSan Antonio$19.9M
- Bonnie ColvilleHouston$19.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.